Cancer Epidemiol Biomarkers Prev. 2010 Jun 15.
Association between Genetic Variants in the 8q24 Cancer Risk Regions and Circulating Levels of Androgens and Sex Hormone-Binding Globulin.
http://www.ncbi.nlm.nih.gov/pubmed/20551303
Thursday, June 17, 2010
China: University of Hong Kong_potential Head and neck tumor suppressor (metalloprotease family member ADAMTS9)
Cancer Res. 2010 Jun 15.
Extracellular Protease ADAMTS9 Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis.
http://www.ncbi.nlm.nih.gov/pubmed/20551050
Extracellular Protease ADAMTS9 Suppresses Esophageal and Nasopharyngeal Carcinoma Tumor Formation by Inhibiting Angiogenesis.
http://www.ncbi.nlm.nih.gov/pubmed/20551050
Wednesday, June 16, 2010
China: Huazhong University of Science and Technology_A potential biomarker (X-ray repair cross-complementing 1)for breast cancer
Breast Cancer Res Treat. 2010 Jun 13.
A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer.
http://www.ncbi.nlm.nih.gov/pubmed/20549339
A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer.
http://www.ncbi.nlm.nih.gov/pubmed/20549339
China: Sun Yat-sen University_A biomarket or therapy (MicroRNA-125b) for bladder cancer
Int J Cancer. 2010 Jun 14.
MicroRNA-125b suppresses the development of bladder cancer by Targeting E2F3.
http://www.ncbi.nlm.nih.gov/pubmed/20549700
MicroRNA-125b suppresses the development of bladder cancer by Targeting E2F3.
http://www.ncbi.nlm.nih.gov/pubmed/20549700
China: Disease Control and Prevention of Shenzhen_ATM C. 1066-6T biomarker for breast cancer under scrutinizing
Breast Cancer Res Treat. 2010 Jun 11.
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
http://www.ncbi.nlm.nih.gov:80/pubmed/20544271
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
http://www.ncbi.nlm.nih.gov:80/pubmed/20544271
Subscribe to:
Posts (Atom)
alveice Team. Powered by Blogger.